Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial

BACKGROUND: In oncology, detection and tracking of adverse events are of top priority and rely mostly on the Common Terminology Criteria for Adverse Events (CTCAE). Besides, clinical trials use as well patient-reported outcomes (PROs) to assess those adverse events, which are only accessible through...

Descripción completa

Detalles Bibliográficos
Autores principales: Wintner, Lisa M., Giesinger, Johannes M., Sztankay, Monika, Bottomley, Andrew, Holzner, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552957/
https://www.ncbi.nlm.nih.gov/pubmed/33050917
http://dx.doi.org/10.1186/s13063-020-04745-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552957/
https://www.ncbi.nlm.nih.gov/pubmed/33050917
http://dx.doi.org/10.1186/s13063-020-04745-w

Ejemplares similares